Navigation Links
Amgen To Webcast 2013 Business Review Meeting On February 7
Date:1/31/2013

THOUSAND OAKS, Calif., Jan. 31, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will hold its Business Review Meeting on Thursday, Feb. 7, 2013, at the Mandarin Oriental Hotel, 80 Columbus Circle, New York City, beginning at 8 a.m. Eastern Standard Time. In the meeting, Robert A. Bradway , chairman and chief executive officer, Sean E. Harper , M.D., executive vice president, Research and Development, Anthony C. Hooper , executive vice president, Global Commercial Operations, and Jonathan M. Peacock , executive vice president and chief financial officer, will discuss the Company's plans to manage our diversified portfolio of in-market products, a strong emerging pipeline, and other initiatives that will drive future growth.

The webcast will be available to members of the news media, investors and the general public, and is expected to last approximately four hours.

The webcast of the meeting, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability, and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay at least 30 days after the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have change
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 FDNA présentera ... série de démonstrations personnelles   FDNA® ... de l,analyse de la dysmorphologie assistée par ... lors de la réunion ASHG 2014, qui se ... , en Californie. FDNA présentera la dernière ...
(Date:9/23/2014)... , September 23, 2014 ... l,automobile, la santé, le ferroviaire ou encore ... connectées, donneront progressivement accès à leurs données. ... nombreux capteurs installés au cœur des voitures, ... plusieurs dizaines de milliards le nombre de ...
(Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
Breaking Medicine Technology:FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 3Altran transforme le big data du monde industriel en nouveau business 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4
... July 11, 2007 /PRNewswire/ -- Inspiration,Biopharmaceuticals today ... development of new, proprietary forms of,recombinant Factor ... The data,were highlighted in an oral presentation ... of the International Society on Thrombosis and,Haemostasis ...
... Study in American Heart Journal , ,WINNIPEG, ... a cardiovascular focused, biopharmaceutical company,today announced that the ... Tirofiban and Sirolimus-Eluting,Stent Versus Abciximab and Bare Metal ... the July edition of the Journal,of the American ...
Cached Medicine Technology:Inspiration Biopharmaceuticals Presents Data From Hemophilia,Program at International Society On Thrombosis and Haemostasis,(ISTH) Annual Meeting 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5
(Date:9/23/2014)... By Kathleen Doheny ... -- For babies born at very low birth weights, breast ... to a potentially dangerous infection known as cytomegalovirus (CMV), a ... very low birth weight infants -- all of whom weighed ... mothers with a history of CMV infection, to see whether ...
(Date:9/23/2014)... bringing with its advances promises of individualized genetic ... interventions. Genetic tests are already guiding treatments ... c virus (HPC), and emerging research is showing ... an individual,s susceptibility to addiction to a substance, ... there appear to be many benefits inherent in ...
(Date:9/23/2014)... 23, 2014 What: Rutgers Presbyterian ... West Side that embodies the inclusion and diversity ... Scripture and the Ecological Crisis, a public lecture ... Professor Emerita of Old Testament at Louisville Presbyterian ... wisdom that lends insight into current ecological problems, ...
(Date:9/23/2014)... already obese as teenagers could grow up to earn ... normal weight. So says Petter Lundborg of Lund University, ... Linneas University and Lund University, all in Sweden. The ... and the United States, and the results are published ... researchers analyzed large-scale data of 145,193 Swedish-born brothers who ...
(Date:9/23/2014)... September 23, 2014 Trevera provides ... market. Included are Oracle Managed Services , ... supports all versions of Oracle E-Business Databases ... , Trevera has announced a significant enhancement ... need help with their software technology management, project ...
Breaking Medicine News(10 mins):Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Note to young men: Fat doesn't pay 2Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3
... Eye Research Institute (SERI) found that increasing the contrast ... enjoyable to the visually impaired. // ,The U.S. ... device to help millions suffering eye diseases. People who ... from macular degeneration, diabetic retinopathy and other causes of ...
... family and community medicine and colleagues developed the latest tool ... developed a tool which is called the Newest vital sign. ... based on an ice cream nutrition label. Based on the ... literacy can be calculated. , Then it is ...
... has been legalized in Canada the sex workers feel that the ... public for negotiating with their customers in public and does not ... rented flat.// The sex workers organization feels that the law will ... to brutality and killing, as they are not sure about the ...
... undergo a liver transplant at the St James's University Hospital in ... to take as long as 10 hours, in which half the ... ,Lennox developed chronic liver problems and jaundice within weeks after his ... a transplant appeared to be the only way of saving his ...
... San Diego have designed mice containing fully functional human nerve ... neurodegenerative diseases such as Parkinson's and Alzheimer's. // ... the neurons were formed in the brains of mice that ... embryos. ,Studies showed that the human stem ...
... The human brain can be manipulated to get relief from ... University in California. ,As many as eight patients were ... brains while performing // mental exercises. Standard therapy has ... possibilities can be opened through the results of the research. ...
Cached Medicine News:Health News:Visually impaired prefer specially enhanced TV 2Health News:Visually impaired prefer specially enhanced TV 3Health News:Human neurons grown in the brains of mice 2
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... 30° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
... High-Mag 1.5x is specifically designed ... in macular hole surgery, optic ... membrane removal, traditional macular edema ... magnification. This lens was developed ...
... Chalam Flat is designed for ... and induction of posterior vitreous ... for macula whole surgery, epiretinal ... tractional epiretinal membranes. Direct image ...
Medicine Products: